maaf email atau password anda salah

Misbehaving Pharmaceutical Companies Should be Punished

Monday, October 31, 2022

The pharmaceutical industry is in turmoil following the outbreak of acute kidney failure cases. Tempo interviewed Indonesian Pharmaceutical Companies Association Executive Director Elfiano Rizaldi regarding the matter.

arsip tempo : 173484444517.

GP Farmasi Executive Director Elfiano Rizaldi TEMPO/Hussein Abri Dongoran . tempo : 173484444517.

THE pharmaceutical industry was shaken when the health ministry banned the sales of syrup medicines on October 18. Syrup medicines are suspected to be behind the sharp increase of cases of acute kidney injury throughout this year. Two days later, the Food and Drugs Monitoring Agency (BPOM) released a list of five medicines indicated to contain ethylene glycol (EG), diethylene glycol (DEG) and ethylene glycol butyl ether (EGBE).

Indonesian Pharm...

Subscribe to continue reading.
We craft news with stories.

For the benefits of subscribing to Digital Tempo, See More

The Best Choice

Rp 54.945/Month

Active for 12 Months, Rp 659.340

  • *You Save -Rp 102.000
  • *Guaranteed update of up to 52 Editions of Tempo Magazine

Rp 64.380/Month

Active Every Month Cancel Anytime

  • *Free for the first month if using a Credit Card

See Other Packages

Already a Subscribed? Log in here
To receive daily news by Email, Sign up for Tempo ID.

More Articles

More exclusive contents

  • December 16, 2024

  • December 9, 2024

  • December 2, 2024

  • November 25, 2024

Independent journalism needs public support. By subscribing to Tempo, you will contribute to our ongoing efforts to produce accurate, in-depth and reliable information. We believe that you and everyone else can make all the right decisions if you receive correct and complete information. For this reason, since its establishment on March 6, 1971, Tempo has been and will always be committed to hard-hitting investigative journalism. For the public and the Republic.

Login Subscribe